Guidance for Ionis Pharma (IONS)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2026 | N/A | N/A | $800.00M – 825.00M | $914.40M | = Maintained | Details |
| 2025 | $875.00 – $900.00 | $866.50 | N/A | N/A | = Maintained | Details |
| 2025 | N/A | N/A | $825.00M – 850.00M | $755.80M | = Maintained | Details |
| 2025 | N/A | N/A | $725.00M – 750.00M | $653.50M | = Maintained | Details |
| 2025 | N/A | N/A | $600.00M | $677.10M | = Maintained | Details |
| Q1 2024 | N/A | N/A | $575.00M | N/A | = Maintained | Details |
| 2022 | N/A | N/A | $575.00M | $595.00M | = Maintained | Details |
| 2021 | N/A | N/A | $600.00M | $618.00M | = Maintained | Details |
| 2021 | N/A | N/A | $600.00M | $781.31M | = Maintained | Details |
| 2020 | N/A | N/A | $700.00M | $814.68M | = Maintained | Details |
| 2019 | N/A | N/A | $1.00B | $0.83B | = Maintained | Details |
| 2019 | N/A | N/A | $725.00M | N/A | = Maintained | Details |
| Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q2 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
